KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Return on Assets (2016 - 2025)

Historic Return on Assets for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to 0.08%.

  • Neogenomics' Return on Assets fell 300.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.05% for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, Neogenomics' Return on Assets is 0.08%, which was down 300.0% from 0.07% recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Return on Assets registered a high of 0.04% during Q2 2021, and its lowest value of 0.09% during Q3 2022.
  • For the 5-year period, Neogenomics' Return on Assets averaged around 0.05%, with its median value being 0.05% (2024).
  • In the last 5 years, Neogenomics' Return on Assets surged by 500bps in 2021 and then plummeted by -1200bps in 2022.
  • Over the past 5 years, Neogenomics' Return on Assets (Quarter) stood at 0.0% in 2021, then plummeted by -1767bps to 0.08% in 2022, then surged by 37bps to 0.05% in 2023, then increased by 8bps to 0.05% in 2024, then tumbled by -71bps to 0.08% in 2025.
  • Its last three reported values are 0.08% in Q3 2025, 0.07% for Q2 2025, and 0.05% during Q1 2025.